Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 1997

Study Completion Date

December 31, 2002

Conditions

CarcinomaPeritoneal Neoplasm

Interventions

DRUG

Cisplatin

DRUG

Paclitaxel

DRUG

5-FU

Trial Locations (1)

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH